-transparent.png){kind=logo}
Overall 2-year actuarial survival rates were 77 and 81 per cent in a high and a low dose rate group, respectively. In the high dose rate group 60 patients were controlled, 8 developed rectal bleeding, and 7 recurred. In the low dose rate group 54 were controlled, one developed rectal bleeding, and 9 recurred. Optimum TDF was 125 in both groups.
Related Publications
T Inoue, and
S Hori, and
Y Miyata, and
S Ozeki, and
Y Shigematsu
September 2001,
Japanese journal of clinical oncology,
T Inoue, and
S Hori, and
Y Miyata, and
S Ozeki, and
Y Shigematsu
January 2002,
Cancer,
T Inoue, and
S Hori, and
Y Miyata, and
S Ozeki, and
Y Shigematsu
September 1990,
International journal of radiation oncology, biology, physics,
T Inoue, and
S Hori, and
Y Miyata, and
S Ozeki, and
Y Shigematsu
November 1985,
Gan no rinsho. Japan journal of cancer clinics,
T Inoue, and
S Hori, and
Y Miyata, and
S Ozeki, and
Y Shigematsu
October 1994,
Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
T Inoue, and
S Hori, and
Y Miyata, and
S Ozeki, and
Y Shigematsu
March 1990,
Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
T Inoue, and
S Hori, and
Y Miyata, and
S Ozeki, and
Y Shigematsu
December 1990,
International journal of radiation oncology, biology, physics,
T Inoue, and
S Hori, and
Y Miyata, and
S Ozeki, and
Y Shigematsu
July 1997,
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
T Inoue, and
S Hori, and
Y Miyata, and
S Ozeki, and
Y Shigematsu
November 1989,
Rinsho hoshasen. Clinical radiography,
T Inoue, and
S Hori, and
Y Miyata, and
S Ozeki, and
Y Shigematsu
January 1996,
The British journal of radiology,
